The Emergence of Reduced Ciprofloxacin Susceptibility in Salmonella enterica Causing Bloodstream Infections in Rural Ghana.

BACKGROUND Salmonella ranks among the leading causes of bloodstream infections in sub-Saharan Africa. Multidrug resistant typhoidal and nontyphoidal Salmonella (NTS) isolates have been previously identified in this region. However, resistance to ciprofloxacin has rarely been reported in West Africa. This study aims to assess susceptibility against ciprofloxacin in Salmonella causing invasive bloodstream infections among children in rural Ghana. METHODS From May 2007 until May 2012, children attending a rural district hospital in central Ghana were eligible for recruitment. Salmonella enterica isolated from blood cultures were assessed for ciprofloxacin susceptibility by Etest (susceptible minimum inhibitory concentration [MIC] ≤ 0.06 µg/mL). The gyrA, gyrB, parC, and parE genes were sequenced to identify mutations associated with changes in susceptibility to fluoroquinolones. RESULTS Two hundred eighty-five Salmonella enterica isolates from 5211 blood cultures were most commonly identified as Salmonella enterica serovar Typhimurium (n = 129 [45%]), Salmonella enterica serovar Typhi (n = 89 [31%]), Salmonella enterica serovar Dublin (n = 20 [7%]), and Salmonella enterica serovar Enteritidis (n = 19 [7%]). All S. Typhi and S. Dublin were susceptible to ciprofloxacin. Reduced susceptibility (MIC >0.06 µg/mL) was found in 53% (10/19) of S. Enteritidis and in 2% (3/129) of S. Typhimurium isolates. Sequencing detected a single gyrB mutation (Glu466Asp) and a single gyrA mutation (Ser83Tyr) in all 3 S. Typhimurium isolates, while 9 of 10 S. Enteritidis harbored single gyrA mutations (Asp87Gly, Asp87Asn, or Asp87Tyr). No mutations were found in the parC and parE genes. CONCLUSIONS Ciprofloxacin susceptibility in invasive NTS in rural Ghana is highly dependent on serotype. Although reduced ciprofloxacin susceptibility is low in S. Typhimurium, more than half of all S. Enteritidis isolates are affected. Healthcare practitioners in Ghana should be aware of potential treatment failure in patients with invasive S. Enteritidis infections.

[1]  S. E. Park,et al.  Detection of a Novel gyrB Mutation Associated With Fluoroquinolone-Nonsusceptible Salmonella enterica serovar Typhimurium Isolated From a Bloodstream Infection in Ghana. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  J. Crump,et al.  Validation and Identification of Invasive Salmonella Serotypes in Sub-Saharan Africa by Multiplex Polymerase Chain Reaction. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  M. Maksoud,et al.  Multi-drug resistance and reduced susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates from the Middle East and Central Asia , 2014, New microbes and new infections.

[4]  A. Kapil,et al.  Revised ciprofloxacin breakpoints for Salmonella Typhi: its implications in India. , 2014, Indian journal of medical microbiology.

[5]  J. Jacobs,et al.  Intermediate Susceptibility to Ciprofloxacin among Salmonella enterica Serovar Typhi Isolates in Lima, Peru , 2013, Journal of Clinical Microbiology.

[6]  P. Horby,et al.  Antibiotic use and resistance in emerging economies: a situation analysis for Viet Nam , 2013, BMC Public Health.

[7]  F. Weill,et al.  Highly drug-resistant Salmonella enterica serotype Kentucky ST198-X1: a microbiological study. , 2013, The Lancet. Infectious diseases.

[8]  J. Jacobs,et al.  Antimicrobial Resistance in Invasive Non-typhoid Salmonella from the Democratic Republic of the Congo: Emergence of Decreased Fluoroquinolone Susceptibility and Extended-spectrum Beta Lactamases , 2013, PLoS neglected tropical diseases.

[9]  Sophie Bertrand,et al.  Azithromycin and Ciprofloxacin Resistance in Salmonella Bloodstream Infections in Cambodian Adults , 2012, PLoS neglected tropical diseases.

[10]  F. Aarestrup,et al.  In vitro susceptibility testing of fluoroquinolone activity against Salmonella: recent changes to CLSI standards. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  J. Wain,et al.  Intra-continental spread of human invasive Salmonella Typhimurium pathovariants in sub-Saharan Africa , 2012, Nature Genetics.

[12]  Anne Caroline Krefis,et al.  Incidence and Characteristics of Bacteremia among Children in Rural Ghana , 2012, PloS one.

[13]  G. Dougan,et al.  Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa , 2012, The Lancet.

[14]  W. Rabsch,et al.  Bacteremia and Antimicrobial Drug Resistance over Time, Ghana , 2011, Emerging infectious diseases.

[15]  A. Agyekum,et al.  Typhoid Fever among Children, Ghana , 2010, Emerging infectious diseases.

[16]  G. Pluschke,et al.  Single Nucleotide Polymorphism Typing of Mycobacterium ulcerans Reveals Focal Transmission of Buruli Ulcer in a Highly Endemic Region of Ghana , 2010, PLoS neglected tropical diseases.

[17]  J. Crump,et al.  Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. , 2010, The Lancet. Infectious diseases.

[18]  A. Muigai,et al.  Trends in Salmonella enteric serovar Typhi in Nairobi, Kenya from 2004 to 2006. , 2010, Journal of infection in developing countries.

[19]  Aamir Fazil,et al.  The global burden of nontyphoidal Salmonella gastroenteritis. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  M. Levine,et al.  Identification by PCR of Non-typhoidal Salmonella enterica Serovars Associated with Invasive Infections among Febrile Patients in Mali , 2010, PLoS neglected tropical diseases.

[21]  J. Crump,et al.  Global trends in typhoid and paratyphoid Fever. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  G. Dougan,et al.  Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotype. , 2009, Genome research.

[23]  S. Ricke,et al.  Identification of Salmonella enterica subspecies I, Salmonella enterica serovars Typhimurium, Enteritidis and Typhi using multiplex PCR. , 2009, FEMS microbiology letters.

[24]  J. Jacobs,et al.  Antibiotic resistance among bacterial pathogens in Central Africa: a review of the published literature between 1955 and 2008. , 2009, International journal of antimicrobial agents.

[25]  J. Crump,et al.  Invasive non-Typhi Salmonella disease in Africa. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  K. Keddy,et al.  Quinolone-resistant Salmonella Typhi in South Africa, 2003–2007 , 2009, Epidemiology and Infection.

[27]  Jian-Hua Liu,et al.  Coprevalence of Plasmid-Mediated Quinolone Resistance Determinants QepA, Qnr, and AAC(6′)-Ib-cr among 16S rRNA Methylase RmtB-Producing Escherichia coli Isolates from Pigs , 2008, Antimicrobial Agents and Chemotherapy.

[28]  M. Molyneux,et al.  Epidemics of invasive Salmonella enterica serovar enteritidis and S. enterica Serovar typhimurium infection associated with multidrug resistance among adults and children in Malawi. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  J. Wain,et al.  Antimicrobial Drug Resistance of Salmonella enterica Serovar Typhi in Asia and Molecular Mechanism of Reduced Susceptibility to the Fluoroquinolones , 2007, Antimicrobial Agents and Chemotherapy.

[30]  K. Kimura,et al.  New Plasmid-Mediated Fluoroquinolone Efflux Pump, QepA, Found in an Escherichia coli Clinical Isolate , 2007, Antimicrobial Agents and Chemotherapy.

[31]  A. Robicsek,et al.  qnr Prevalence in Ceftazidime-Resistant Enterobacteriaceae Isolates from the United States , 2006, Antimicrobial Agents and Chemotherapy.

[32]  A. Cheng,et al.  Mutations in Topoisomerase Genes of Fluoroquinolone-Resistant Salmonellae in Hong Kong , 2003, Antimicrobial Agents and Chemotherapy.

[33]  Sherilyn J. Sawyer,et al.  Identification by Subtractive Hybridization of Sequences Specific for Salmonella enterica Serovar Enteritidis , 2001, Applied and Environmental Microbiology.

[34]  H. Imberechts,et al.  The AcrB multidrug transporter plays a major role in high-level fluoroquinolone resistance in Salmonella enterica serovar typhimurium phage type DT204. , 2002, Microbial drug resistance.